The Biotech industry is up 6.2% in the last week, with PharmaEssentia up 15%. However, the industry is down 11% over the past year. Looking forward, earnings are forecast to grow by 70% annually.
Has the Taiwanese Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Mon, 27 May 2024 | NT$489.1b | NT$21.9b | -NT$11,084,581,000.00 | 42x | -44.1x | 22.3x |
Wed, 24 Apr 2024 | NT$433.7b | NT$21.1b | -NT$12,242,614,000.00 | 47.2x | -35.4x | 20.5x |
Fri, 22 Mar 2024 | NT$432.2b | NT$21.1b | -NT$10,210,083,000.00 | 50.2x | -42.3x | 20.5x |
Sun, 18 Feb 2024 | NT$443.1b | NT$19.9b | -NT$9,857,794,000.00 | 40.3x | -44.9x | 22.3x |
Tue, 16 Jan 2024 | NT$462.0b | NT$19.8b | -NT$9,748,146,000.00 | 40.4x | -47.4x | 23.4x |
Thu, 14 Dec 2023 | NT$469.4b | NT$19.9b | -NT$9,737,975,000.00 | 43.1x | -48.2x | 23.6x |
Sat, 11 Nov 2023 | NT$471.4b | NT$18.5b | -NT$10,820,022,000.00 | 48.2x | -43.6x | 25.4x |
Mon, 09 Oct 2023 | NT$472.2b | NT$18.3b | -NT$10,774,226,000.00 | 45.1x | -43.8x | 25.8x |
Wed, 06 Sep 2023 | NT$486.9b | NT$18.3b | -NT$10,596,353,000.00 | 43.2x | -45.9x | 26.6x |
Fri, 04 Aug 2023 | NT$464.5b | NT$18.6b | -NT$10,793,316,000.00 | 50.2x | -43x | 25x |
Sun, 02 Jul 2023 | NT$490.2b | NT$18.7b | -NT$10,709,428,000.00 | 43.9x | -45.8x | 26.3x |
Tue, 30 May 2023 | NT$493.5b | NT$18.9b | -NT$10,006,444,000.00 | 42x | -49.3x | 26.1x |
Thu, 27 Apr 2023 | NT$502.6b | NT$18.5b | -NT$9,801,895,000.00 | 43.3x | -51.3x | 27.2x |
Sat, 25 Mar 2023 | NT$504.2b | NT$20.5b | -NT$9,043,868,000.00 | 37.3x | -55.7x | 24.6x |
Mon, 20 Feb 2023 | NT$521.9b | NT$21.8b | -NT$7,840,926,000.00 | 38x | -66.6x | 23.9x |
Wed, 18 Jan 2023 | NT$494.2b | NT$21.8b | -NT$7,778,690,000.00 | 36.2x | -63.5x | 22.7x |
Fri, 16 Dec 2022 | NT$515.0b | NT$21.8b | -NT$7,522,211,000.00 | 37.2x | -68.5x | 23.6x |
Sun, 13 Nov 2022 | NT$494.5b | NT$23.1b | -NT$6,713,023,000.00 | 37.5x | -73.7x | 21.4x |
Tue, 11 Oct 2022 | NT$511.2b | NT$23.1b | -NT$6,633,590,000.00 | 38.2x | -77.1x | 22.1x |
Thu, 08 Sep 2022 | NT$639.6b | NT$23.0b | -NT$6,491,301,000.00 | 44.8x | -98.5x | 27.8x |
Sat, 06 Aug 2022 | NT$545.9b | NT$22.6b | -NT$5,727,813,000.00 | 32.8x | -95.3x | 24.2x |
Mon, 04 Jul 2022 | NT$511.3b | NT$22.5b | -NT$5,642,821,000.00 | 30.6x | -90.6x | 22.7x |
Wed, 01 Jun 2022 | NT$503.0b | NT$22.5b | -NT$5,642,821,000.00 | 31.9x | -89.1x | 22.3x |
Fri, 29 Apr 2022 | NT$519.3b | NT$21.4b | -NT$5,787,788,000.00 | 45.3x | -89.7x | 24.2x |
Sun, 27 Mar 2022 | NT$523.4b | NT$19.7b | -NT$4,772,627,000.00 | 27.8x | -109.7x | 26.6x |
Tue, 22 Feb 2022 | NT$484.8b | NT$17.9b | -NT$5,564,340,000.00 | 25x | -87.1x | 27.1x |
Thu, 20 Jan 2022 | NT$430.1b | NT$17.9b | -NT$5,532,702,000.00 | 24.9x | -77.7x | 24x |
Sat, 18 Dec 2021 | NT$462.4b | NT$17.9b | -NT$5,579,296,000.00 | 26.5x | -82.9x | 25.8x |
Mon, 15 Nov 2021 | NT$354.1b | NT$15.6b | -NT$7,380,599,000.00 | 20.3x | -48x | 22.7x |
Wed, 13 Oct 2021 | NT$335.2b | NT$15.4b | -NT$7,624,179,000.00 | 19.6x | -44x | 21.8x |
Fri, 10 Sep 2021 | NT$385.5b | NT$15.4b | -NT$7,624,179,000.00 | 22x | -50.6x | 25.1x |
Sun, 08 Aug 2021 | NT$398.7b | NT$15.4b | -NT$7,624,179,000.00 | 21.2x | -52.3x | 25.9x |
-48x
How does Taiwanese Biotech compare with similar industries?
TW Market | 1.41% | |
Healthcare | -1.12% | |
Biotech | -0.16% | |
Biotech | -0.16% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
4728 Sunmax Biotechnology | NT$288.00 | 18.5% +NT$2.5b | 20.8% | PE23.3x | |
6446 PharmaEssentia | NT$424.00 | 1.4% +NT$2.0b | 22.7% | PE318.3x | |
6541 Tanvex BioPharma | NT$38.55 | 4.3% +NT$262.4m | -52.1% | PS182.6x | |
6794 UnicoCell Biomed | NT$85.90 | 3.5% +NT$161.5m | -2.9% | PS204.4x | |
3176 Medigen Biotechnology | NT$42.15 | 2.8% +NT$160.1m | 26.8% | PS4.7x |